BACKGROUND: The events leading up to the development of new multiple sclerosis (MS) lesions on conventional imaging are unknown. The purpose of this study is to use diffusion tensor imaging (DTI) to investigate prelesional changes in MS to better understand the pathological changes that lead to lesion development. METHODS: Twenty-one patients with relapsing MS starting natalizumab therapy underwent serial DTI for 12-18 months. Regions of interest were outlined within normal-appearing white matter and new gadolinium-enhancing lesions that developed over the course of the study. Images from all time points were coregistered and nonparametric regression was used to assess DTI changes prior to lesion appearance. RESULTS: A total of 31 newly enhancing lesions were identified. Significant changes in transverse diffusivity (TD) (P < .001), longitudinal diffusivity (LD) (P = .025), mean diffusivity (MD) (P < .001), and fractional anisotropy (FA) (P = .04) were observed prior to gadolinium enhancement. A progressive increase in TD and LD occurred up to 10 months prior to lesion development. DTI measures in normal appearing white matter remained unchanged over the study period. CONCLUSIONS: A significant change in diffusion measures can be seen prior to gadolinium enhancement. Changes in TD drove changes in FA and MD, providing evidence for impaired myelin integrity prior to gadolinium enhancement. DTI may be a sensitive measure for early detection of inflammatory disease activity in MS.
BACKGROUND: The events leading up to the development of new multiple sclerosis (MS) lesions on conventional imaging are unknown. The purpose of this study is to use diffusion tensor imaging (DTI) to investigate prelesional changes in MS to better understand the pathological changes that lead to lesion development. METHODS: Twenty-one patients with relapsing MS starting natalizumab therapy underwent serial DTI for 12-18 months. Regions of interest were outlined within normal-appearing white matter and new gadolinium-enhancing lesions that developed over the course of the study. Images from all time points were coregistered and nonparametric regression was used to assess DTI changes prior to lesion appearance. RESULTS: A total of 31 newly enhancing lesions were identified. Significant changes in transverse diffusivity (TD) (P < .001), longitudinal diffusivity (LD) (P = .025), mean diffusivity (MD) (P < .001), and fractional anisotropy (FA) (P = .04) were observed prior to gadolinium enhancement. A progressive increase in TD and LD occurred up to 10 months prior to lesion development. DTI measures in normal appearing white matter remained unchanged over the study period. CONCLUSIONS: A significant change in diffusion measures can be seen prior to gadolinium enhancement. Changes in TD drove changes in FA and MD, providing evidence for impaired myelin integrity prior to gadolinium enhancement. DTI may be a sensitive measure for early detection of inflammatory disease activity in MS.
Authors: David S Tuch; Timothy G Reese; Mette R Wiegell; Nikos Makris; John W Belliveau; Van J Wedeen Journal: Magn Reson Med Date: 2002-10 Impact factor: 4.668
Authors: D E Goodkin; W D Rooney; R Sloan; P Bacchetti; L Gee; M Vermathen; E Waubant; M Abundo; S Majumdar; S Nelson; M W Weiner Journal: Neurology Date: 1998-12 Impact factor: 9.910
Authors: M C Tartaglia; S Narayanan; N De Stefano; R Arnaoutelis; S B Antel; S J Francis; A C Santos; Y Lapierre; D L Arnold Journal: J Neurol Date: 2002-10 Impact factor: 4.849
Authors: Cynthia A DeBoy; Jiangyang Zhang; Sonny Dike; Irina Shats; Melina Jones; Daniel S Reich; Susumu Mori; Thien Nguyen; Brian Rothstein; Robert H Miller; John T Griffin; Douglas A Kerr; Peter A Calabresi Journal: Brain Date: 2007-06-08 Impact factor: 13.501
Authors: Kelley C Atkinson; Jeong Bin Lee; Jonathan P C Hasselmann; Sung Hoon Kim; Alyson Drew; Joselyn Soto; John A Katzenellenbogen; Neil G Harris; Andre Obenaus; Seema K Tiwari-Woodruff Journal: Neurobiol Dis Date: 2019-06-18 Impact factor: 5.996
Authors: Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang Journal: Neurobiol Aging Date: 2016-09-28 Impact factor: 4.673
Authors: Eva Heckova; Bernhard Strasser; Gilbert J Hangel; Michal Považan; Assunta Dal-Bianco; Paulus S Rommer; Petr Bednarik; Stephan Gruber; Fritz Leutmezer; Hans Lassmann; Siegfried Trattnig; Wolfgang Bogner Journal: Invest Radiol Date: 2019-04 Impact factor: 6.016
Authors: Leah H Suttner; Amanda Mejia; Blake Dewey; Pascal Sati; Daniel S Reich; Russell T Shinohara Journal: Neuroimage Clin Date: 2016-09-14 Impact factor: 4.881
Authors: Katline Metzger-Peter; Laurent Daniel Kremer; Gilles Edan; Paulo Loureiro De Sousa; Julien Lamy; Dominique Bagnard; Ayikoe-Guy Mensah-Nyagan; Thibault Tricard; Guillaume Mathey; Marc Debouverie; Eric Berger; Anne Kerbrat; Nicolas Meyer; Jérôme De Seze; Nicolas Collongues Journal: Trials Date: 2020-06-29 Impact factor: 2.279
Authors: Jenny Feng; Erik Offerman; Jian Lin; Elizabeth Fisher; Sarah M Planchon; Ken Sakaie; Mark Lowe; Kunio Nakamura; Jeffrey A Cohen; Daniel Ontaneda Journal: Mult Scler J Exp Transl Clin Date: 2019-06-14